Li DL - Search Results

1

Broad LM, Mogg AJ, Eberle E, Tolley M, Li DL, Knopp KL. Broad LM, et al. Among authors: li dl. Pharmaceuticals (Basel). 2016 Sep 9;9(3):55. doi: 10.3390/ph9030055. Pharmaceuticals (Basel). 2016. PMID: 27618069 Free PMC article. Review.

2

Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models.

Johnson MP, Muhlhauser MA, Nisenbaum ES, Simmons RM, Forster BM, Knopp KL, Yang L, Morrow D, Li DL, Kennedy JD, Swanson S, Monn JA. Johnson MP, et al. Among authors: li dl. Br J Pharmacol. 2017 May;174(9):822-835. doi: 10.1111/bph.13740. Epub 2017 Mar 13. Br J Pharmacol. 2017. PMID: 28177520 Free PMC article.

3

Antihyperalgesic effects of the muscarinic receptor ligand vedaclidine in models involving central sensitization in rats.

Shannon HE, Jones CK, Li DL, Peters SC, Simmons RMA, Iyengar S. Shannon HE, et al. Among authors: li dl. Pain. 2001 Sep;93(3):221-227. doi: 10.1016/S0304-3959(01)00319-0. Pain. 2001. PMID: 11514081

4

Identification of a high-affinity binding site involved in the transport of endocannabinoids.

Moore SA, Nomikos GG, Dickason-Chesterfield AK, Schober DA, Schaus JM, Ying BP, Xu YC, Phebus L, Simmons RM, Li D, Iyengar S, Felder CC. Moore SA, et al. Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17852-7. doi: 10.1073/pnas.0507470102. Epub 2005 Nov 28. Proc Natl Acad Sci U S A. 2005. PMID: 16314570 Free PMC article.

5

3-Aryl-1,2-diacetamidopropane derivatives as novel and potent NK-1 receptor antagonists.

Hipskind PA, Howbert JJ, Bruns RF, Cho SS, Crowell TA, Foreman MM, Gehlert DR, Iyengar S, Johnson KW, Krushinski JH, Li DL, Lobb KL, Mason NR, Muehl BS, Nixon JA, Phebus LA, Regoli D, Simmons RM, Threlkeld PG, Waters DC, Gitter BD. Hipskind PA, et al. Among authors: li dl. J Med Chem. 1996 Feb 2;39(3):736-48. doi: 10.1021/jm950616c. J Med Chem. 1996. PMID: 8576917

6

LY303870, a centrally active neurokinin-1 antagonist with a long duration of action.

Iyengar S, Hipskind PA, Gehlert DR, Schober D, Lobb KL, Nixon JA, Helton DR, Kallman MJ, Boucher S, Couture R, Li DL, Simmons RM. Iyengar S, et al. Among authors: li dl. J Pharmacol Exp Ther. 1997 Feb;280(2):774-85. J Pharmacol Exp Ther. 1997. PMID: 9023291

7

Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?

Iyengar S, Li DL, Simmons RM. Iyengar S, et al. Among authors: li dl. J Pharmacol Exp Ther. 1999 May;289(2):1031-40. J Pharmacol Exp Ther. 1999. PMID: 10215684

8

Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat.

Simmons RM, Li DL, Hoo KH, Deverill M, Ornstein PL, Iyengar S. Simmons RM, et al. Among authors: li dl. Neuropharmacology. 1998;37(1):25-36. doi: 10.1016/s0028-3908(97)00188-3. Neuropharmacology. 1998. PMID: 9680256

9

Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 receptors as examples.

Chernet E, Martin LJ, Li D, Need AB, Barth VN, Rash KS, Phebus LA. Chernet E, et al. Life Sci. 2005 Dec 12;78(4):340-6. doi: 10.1016/j.lfs.2005.04.075. Epub 2005 Sep 1. Life Sci. 2005. PMID: 16139310

10

5HT1A receptor antagonists enhance the functional activity of fluoxetine in a mouse model of feeding.

Li DL, Simmons RM, Iyengar S. Li DL, et al. Brain Res. 1998 Jan 19;781(1-2):121-8. doi: 10.1016/s0006-8993(97)01221-3. Brain Res. 1998. PMID: 9507085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

528 results

Search Page